Brief: CK Life Sciences Intl Says Unit, Quark And Pharus Entered A Subscription Agreement
July 25 (Reuters) - CK Life Sciences Intl (Holdings) Inc
0775.HK :
* UNIT, QUARK AND PHARUS ENTERED INTO A SUBSCRIPTION
AGREEMENT
* INTENDED PHARUS SHALL FOCUS ON RESEARCH, DEVELOPMENT AND
COMMERCIALISATION OF MOLECULAR DIAGNOSTICS FOR EARLY DETECTION
OF CANCER
* CKLS INVESTOR AND CKHH INVESTOR SUBSCRIBED FOR CERTAIN
SERIES A2
PREFERENCE SHARES IN CAPITAL OF PHARUS
Further company coverage: 0775.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CK Life Sciences Intl (Holdings)
See all newsCK Life Sciences H1 loss narrows on lower R&D costs
Brief: CK Life Sciences Intl Announces Resignation Of Lance Richard Lee Yuen As Executive Director, CEO
Brief: CK Life Sciences Intl Logs FY Loss Attributable HK$186.8 Mln
CK Life Sciences rises most in 4 months on advancing cancer vaccine development
Brief: CK Life Sciences Intl Establishes Sequencio Therapeutics For Cancer Vaccine Development